RIGVIR

Medicine containing the oncolytic ECHO-7 virus Rigvir for the treatment of oncological diseases and prevention of metastasis. Several licenses have been issued for the manufacturing, registration, and distribution of the product.
For more information about the product:

Click Here

RIGVIR SE

Food supplement containing ECHO-7 virus Rigvir. Recommended to people with a weakened immune system and with an increased risk of developing cancer. An exclusive license has been issued to the company Smart Nanovirus Limited, UK for the use of the virus Rigvir in non-medical product and project development.
For more information:

www.smartnanovirus.com

ECHO-7 RIGVIR

An analogue to Rigvir that contains ECHO-7 virus Rigvir. Intended for the needs of science and industry. An exclusive licence for manufacturing and distribution of the virus Rigvir in the science and industry segment is issued to the company Aramapharm Ltd., Estonia.
For more information:

www.aramapharm.com

N.B. Rigvir Group performs constant and independent monitoring of all licensed products containing ECHO-7 virus Rigvir to keep track of product storage conditions according to specifications and virus stability (or presence of the virus) in licensed products.